[1]宋珊珊,李大勇,李 鑫,等.一效膏治疗糖尿病足临床研究[J].陕西中医,2021,(9):1236-1239.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.022]
 SONG Shanshan,LI Dayong,LI Xin,et al.Clinical study on Yixiao ointment in treating diabetic foot[J].,2021,(9):1236-1239.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.022]
点击复制

一效膏治疗糖尿病足临床研究
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1236-1239
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Clinical study on Yixiao ointment in treating diabetic foot
作者:
宋珊珊1李大勇1李 鑫1李帅男2
(1.辽宁中医药大学附属医院,辽宁 沈阳 110000; 2.沈阳市第二中医医院,辽宁 沈阳 110100)
Author(s):
SONG ShanshanLI DayongLI XinLI Shuainan
(The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110000,China)
关键词:
糖尿病足 一效膏 康复新液 足部症状评分 创面渗出 血小板衍生生长因子 血管内皮生长因子
Keywords:
Diabetic foot disease Yixiao ointment Kangfuxin liquid Foot symptom score Wound exudates Platelet-derived growth factor Vascular endothelial growth factor
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.022
文献标志码:
A
摘要:
目的:研究一效膏治疗糖尿病足患者溃疡创面的临床疗效。方法:应用随机数字表法将108例糖尿病足溃疡患者随机分为治疗组54例和对照组54例。两组患者给予基础治疗后,治疗组予一效膏外用治疗,对照组予康复新液外用治疗。观察两组患者治疗前后足部症状评分(包括创面缩小率、肉芽组织填充率、坏死组织附着率、创面渗出、疼痛)、创面组织血管内皮生长因子(VEGF)、血小板衍生生长因子(PDGF)水平变化,比较两组临床疗效及安全性。结果:治疗后,治疗组创面缩小率评分、肉芽组织填充率评分、坏死组织附着率评分、疼痛程度足部症状评分均低于对照组,差异有统计学意义(均P<0.05)。治疗后,治疗组创面组织VEGF、PDGF水平均高于对照组,差异有统计学意义(均P<0.05)。治疗组临床总有效率94.44%,高于对照组的77.78%,组间差异有统计学意义(P<0.05)。治疗期间,两组患者均未发生严重不良反应。结论:一效膏外用治疗糖尿病足溃疡,可明显改善足部症状评分,以及局部VEGF、PDGF水平,临床疗效较好。
Abstract:
Objective:To study the clinical effect of Yixiao ointment on ulcer wound of diabetic foot.Methods:108 patients with diabetic foot ulcer were randomly divided into 54 cases in treatment group and 54 cases in control group according to the digital table method.After basic treatment,the treatment group was treated with Yixiao ointment external treatment and the control group was treated with Kangfuxin liquid external treatment.The foot symptom score(including wound reduction rate,granulation tissue filling rate,necrotic tissue attachment rate,wound exudation,pain),changes in VEGF and PDGF levels in wound tissue,clinical efficacy and safety were compared.Results:The scores of foot symptoms in the treatment group were lower than those in the control group,including wound reduction rate,granulation tissue filling rate score,necrotic tissue attachment rate score,and pain score,difference statistically significant(all P<0.05).The expression of wound tissue VEGF and PDGF in the treatment group were higher than those in the control group,difference statistical significance(all P<0.05).After treatment,the clinical effective rate in the treatment group 94.44% was higher than that in the control group 77.78%,difference statistical significance(P<0.05). Both groups had no serious adverse reactions during the treatment.Conclusion:Yixiao ointment for external use in the treatment of diabetic foot ulcer can significantly improve the foot symptom score,local VEGF,PDGF expression level,clinical effect is good.

参考文献/References:

[1] 中华医学会糖尿病学分会,中华医学会感染病学分会,中华医学会组织修复与再生分会.中国糖尿病足防治指南[J].中华糖尿病杂志,2019,11(2):92-108.
[2] Lazzarini PA,Pacella RE,Armstrong DG,et al.Diabetes-related lower-extremity complications are aleading cause of the global burden of disability[J].Diabet Med,2018,35(9):1297-1299.
[3] 王 旭,佘明明.活血生肌汤联合自体骨髓血干细胞移植对糖尿病足创面的修复作用研究[J].陕西中医,2019,40(10):1364-1366.
[4] Schaper NC,Netten JJ,Apelqvist J,et al.Practical guidelines on the prevention and management of diabetic foot disease[J].Diabetes Metab Res Rev,2020,36(1):326-336.
[5] 中华医学会糖尿病学分会,中华医学会感染病学分会,中华医学会组织修复与再生分会.中国糖尿病足防治指南(2019版)(Ⅱ)[J].中华糖尿病杂志,2019,11(3):161-189.
[6] 中华医学会糖尿病学分会,中华医学会感染病学分会,中华医学会组织修复与再生分会.中国糖尿病足防治指南(2019版)(Ⅲ)[J].中华糖尿病杂志,2019,11(4):238-247.
[7] 中华中医药学会糖尿病分会.糖尿病足中医诊疗标准[J].世界中西医结合杂志,2011,6(7):618-625.
[8] Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association:National cross sectional study[J].BMJ,2020,369(4):997.
[9] 许樟荣.糖尿病足变研究进展[J].中国医师杂志,2004,6(1):1-2.
[10] Wang A,Xu Z,Mu Y,et al.Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in China[J].Int Journal Low Extrem Wouds,2014,13(1):17-21.
[11] 班绎娟,冉兴无,杨 川,等.中国部分省市糖尿病足临床资料和住院费用等比较[J].中华糖尿病杂志,2014,6(7):499-503.
[12] 中国医疗保健国际交流促进会糖尿病足分会.中国糖尿病足诊治指南[J].中华医学杂志,2017,97(4):251-258.
[13] 郭光华,朱 峰,闵定宏,等.糖尿病足合并难愈性创面外科治疗全国专家共识(2020版)[J].中华损伤与修复杂志:电子版,2020,15(4):256-263.
[14] 国际血管联盟中国分会糖尿病足专业委员会.糖尿病足诊治指南[J].介入放射学杂志,2013,22(9):705-708.
[15] 陈 王.象皮粉治疗糖尿病足的临床疗效观察[D].南京:南京中医药大学,2019.
[16] 陈 王,徐 晋.象皮粉治疗糖尿病足的疗效观察[J].河北医药,2019,41(20):3148-3151.
[17] 杨海娜.一效膏促进糖尿病皮肤溃疡愈合的实验研究[D].沈阳:辽宁中医药大学,2018.
[18] 侯俊杰,李大勇,王 晶,等.一效膏配合负压封闭引流治疗重度糖尿足临床经验总结[J].中国中西医结合外科杂志,2019,25(4):614-616.
[19] 买建修,杨会举,刘国平.湿性愈合与煨脓生肌相关性探析[J].辽宁中医杂志,2012,39(9):1730-1732.
[20] 高学敏.中药学[M].北京:中国中医药出版社,2002:224-524.
[21] 国家药典委员会.中华人民共和国药典(一部)[S].北京:化学工业出版社,2000:76-77.
[22] 王 宇,王海波,王艳华.一效膏治疗压疮[J].长春中医药大学学报,2019,35(6):1101-1103.
[23] 蔡 亮,金阿平.解毒通脉方联合湿润烧伤膏治疗糖尿病足患者的疗效观察及对血清VEGF、bFGF、SDF-1α的影响[J].中国中医药科技,2018,25(3):316-321.
[24] 马英丽,姬秋和.清创换药联合康复新液对糖尿病足溃疡的临床疗效观察[J].陕西医学杂志,2016,45(5):636.
[25] 欧栓机,许长鹏,李贵涛,等.胫骨横向骨搬移对血清血管生成相关因子表达的影响[J].中国修复重建外科杂志,2020,34(1):98-101.
[26] 高 艳,崔文钰,卢志强,等.京万红软膏上调PDGF mRNA表达改善大鼠缺血合并外伤型糖尿病足的研究[J].现代药物与临床,2019,34(12):3512-3517.
[27] 易 莲,严胜利,杨丽辉,等.糖足消方治疗早期糖尿病足疗效及对机体氧化应激的影响[J].中国中医药信息杂志,2016,23(12):34-37.
[28] 王少婷,吴佩佩,王振竞,等.补充维生素D对糖尿病足溃疡患者创面愈合、糖代谢、炎症及氧化应激的影响[J].中国医院用药评价与分析,2020,20(8):940-944.
[29] 刘佳莅,姜伟华,夏成勇,等.生肌玉红膏联合封闭负压引流术对糖尿病足患者溃疡创面血管新生及氧化应激指标的影响[J].湖南中医药大学学报,2019,39(2):257-261.

相似文献/References:

[1]王 旭,佘明明△.活血生肌汤联合自体骨髓血干细胞移植对糖尿病足创面的修复作用研究[J].陕西中医,2019,(10):1364.
 WANG Xu,SHE Mingming..Study on the repair effect of Huoxue Shengji decoction combined with autologous bone marrow stem cell transplantation on diabetic foot wounds[J].,2019,(9):1364.
[2]冯海霞,彭新宇,董 峰.阳和汤加减联合银离子敷料治疗糖尿病足溃疡临床研究[J].陕西中医,2021,(7):900.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.023]
[3]吕春燕,徐旭英.名中医徐旭英基于补托法治疗糖尿病足慢性骨髓炎经验[J].陕西中医,2024,(3):391.[doi:DOI:10.3969/j.issn.1000-7369.2024.03.024]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81173273); 辽宁省自然科学基金资助项目(201202154)
更新日期/Last Update: 2021-09-10